LGMN and prostate carcinoma: Limited legumain expression can be detected in normal tissues [3], whereas numerous human cancers, such as ovarian cancer [4], colorectal cancer [5], prostate cancers [6], gastric carcinoma [7], and breast cancers [3] are known to express elevated levels of legumain.